The aim of this umbrella review was to identify tools and guidelines to aid the deprescribing process of potentially inappropriate medications (PIM), evaluate development and validation methods, and describe evidence levels for medication inclusion. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.